Why the study?
Acute kidney injury following cardiac surgery carries an increased risk of death, prompting the need to identify risk factors and evaluate the Leicester score.
Does the Leicester score accurately predict acute kidney injury following cardiac surgery compared to the Cleveland Clinic Score and Euroscore II?
Does the Leicester score accurately predict acute kidney injury following cardiac surgery compared to the Cleveland Clinic Score and Euroscore II?
The Leicester score is a valid tool for predicting acute kidney injury after cardiac surgery, outperforming existing scores like the Cleveland Clinic Score and Euroscore II.
LS may aid CSA-AKI risk stratification post-cardiac surgery; leaves open need for prospective validation before clinical adoption.
The incidence of acute kidney injury following cardiac surgery (CSA-AKI) is up to 30%, and it places patients at an increased risk of death. The Leicester score (LS) is a new score that predicts CSA-AKI of any stage with better discrimination compared to previous scores. The aim of this study was to identify risk factors for CSA-AKI and to assess the performance of LS. A unicentric retrospective study of patients that required cardiac surgery with cardio-pulmonary bypass (CPB) in 2015 was performed. The inclusion criteria were patients over 18 years old who were operated on for cardiac surgery (valve substitution (VS), Coronary Artery Bypass Graft (CABG), or a combination of both procedures and requiring CPB). CSA-AKI was defined with the Kidney Disease Improving Global Outcomes (KDIGO) criteria. In the multivariate analysis, hypertension (odds ratio 1.883), estimated glomerular filtration rate (EGFR) <60 mL/min (2.365), and peripheral vascular disease (4.66) were associated with the outcome. Both discrimination and calibration were better when the LS was used compared to the Cleveland Clinic Score and Euroscore II, with an area under the curve (AUC) of 0.721. In conclusion, preoperative hypertension in patients with CKD with or without peripheral vasculopathy can identify patients who are at risk of CSA-AKI. The LS was proven to be a valid score that could be used to identify patients who are at risk and who could benefit from intervention studies.
No takes yet. Share an insight, caveat, or question.
Molina‐Andújar et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: